These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31963569)

  • 1. The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?
    Provenzano M; Andreucci M; Garofalo C; Faga T; Michael A; Ielapi N; Grande R; Sapienza P; Franciscis S; Mastroroberto P; Serra R
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963569
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis.
    Kobusiak-Prokopowicz M; Kaaz K; Marciniak D; Karolko B; Mysiak A
    Kidney Blood Press Res; 2021; 46(6):749-757. PubMed ID: 34801997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and peripheral arterial disease.
    Busti C; Falcinelli E; Momi S; Gresele P
    Intern Emerg Med; 2010 Feb; 5(1):13-25. PubMed ID: 19626421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic Aneurysms, Chronic Kidney Disease and Metalloproteinases.
    Andreucci M; Provenzano M; Faga T; Michael A; Patella G; Mastroroberto P; Serraino GF; Bracale UM; Ielapi N; Serra R
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
    Narula S; Tandon C; Tandon S
    Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine matrix metalloproteinases and their extracellular inducer EMMPRIN in children with chronic kidney disease.
    Musiał K; Bargenda A; Zwolińska D
    Ren Fail; 2015 Jul; 37(6):980-4. PubMed ID: 25945606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
    Wu CL; Tarng DC
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and involvement of matrix metalloproteinases in vascular diseases.
    Amin M; Pushpakumar S; Muradashvili N; Kundu S; Tyagi SC; Sen U
    Front Biosci (Landmark Ed); 2016 Jan; 21(1):89-118. PubMed ID: 26709763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients.
    Provenzano M; Andreucci M; De Nicola L; Garofalo C; Battaglia Y; Borrelli S; Gagliardi I; Faga T; Michael A; Mastroroberto P; Serraino GF; Licastro N; Ielapi N; Serra R
    Biomed Res Int; 2020; 2020():2314128. PubMed ID: 33102575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
    Chen Y; Peng W; Raffetto JD; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
    Wang X; Khalil RA
    Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix Gelatinases in Atherosclerosis and Diabetic Nephropathy: Progress and Challenges.
    Dimas GG; Didangelos TP; Grekas DM
    Curr Vasc Pharmacol; 2017; 15(6):557-565. PubMed ID: 28155628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extracellular matrix, matrix-degrading proteases and vascular calcification].
    Du YY; Wang X; Kong W
    Sheng Li Ke Xue Jin Zhan; 2008 Jul; 39(3):203-8. PubMed ID: 18819486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.
    Cabral-Pacheco GA; Garza-Veloz I; Castruita-De la Rosa C; Ramirez-Acuña JM; Perez-Romero BA; Guerrero-Rodriguez JF; Martinez-Avila N; Martinez-Fierro ML
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular Calcification: An Important Understanding in Nephrology.
    Zununi Vahed S; Mostafavi S; Hosseiniyan Khatibi SM; Shoja MM; Ardalan M
    Vasc Health Risk Manag; 2020; 16():167-180. PubMed ID: 32494148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
    Peiskerová M; Kalousová M; Kratochvílová M; Dusilová-Sulková S; Uhrová J; Bandúr S; Malbohan IM; Zima T; Tesar V
    Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
    Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.
    Toba H; Lindsey ML
    Pharmacol Ther; 2019 Jan; 193():99-120. PubMed ID: 30149103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
    Chen PM; Wada T; Chiang CK
    Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.